Literature DB >> 30339766

The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer.

Hye Ryun Kim1, Su-Myeong Park2, Sang-Uk Seo2,3, Inkyung Jung1, Hong In Yoon1, Dmitry I Gabrilovich4, Byoung Chul Cho1,5, Seung-Yong Seong2,3, Sang-Jun Ha6, Je-In Youn2,3,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30339766      PMCID： PMC6835091          DOI： 10.1164/rccm.201808-1502LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

1.  CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.

Authors:  Hangyi H Yan; Jian Jiang; Yanli Pang; B R Achyut; Michael Lizardo; Xinhua Liang; Kent Hunter; Chand Khanna; Christine Hollander; Li Yang
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

Review 2.  Understanding the tumor immune microenvironment (TIME) for effective therapy.

Authors:  Mikhail Binnewies; Edward W Roberts; Kelly Kersten; Vincent Chan; Douglas F Fearon; Miriam Merad; Lisa M Coussens; Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Catherine C Hedrick; Robert H Vonderheide; Mikael J Pittet; Rakesh K Jain; Weiping Zou; T Kevin Howcroft; Elisa C Woodhouse; Robert A Weinberg; Matthew F Krummel
Journal:  Nat Med       Date:  2018-04-23       Impact factor: 53.440

Review 3.  Cancer immunotherapy using checkpoint blockade.

Authors:  Antoni Ribas; Jedd D Wolchok
Journal:  Science       Date:  2018-03-22       Impact factor: 47.728

4.  CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.

Authors:  H Zhang; Y-L Ye; M-X Li; S-B Ye; W-R Huang; T-T Cai; J He; J-Y Peng; T-H Duan; J Cui; X-S Zhang; F-J Zhou; R-F Wang; J Li
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

5.  Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.

Authors:  Yoshikane Yamauchi; Seyer Safi; Carolin Blattner; Anchana Rathinasamy; Ludmila Umansky; Simone Juenger; Arne Warth; Martin Eichhorn; Thomas Muley; Felix J F Herth; Hendrik Dienemann; Michael Platten; Philipp Beckhove; Jochen Utikal; Hans Hoffmann; Viktor Umansky
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

6.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

7.  High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.

Authors:  Carsten Krieg; Malgorzata Nowicka; Silvia Guglietta; Sabrina Schindler; Felix J Hartmann; Lukas M Weber; Reinhard Dummer; Mark D Robinson; Mitchell P Levesque; Burkhard Becher
Journal:  Nat Med       Date:  2018-01-08       Impact factor: 87.241

8.  Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome.

Authors:  Astrid Olsnes Kittang; Shahram Kordasti; Kristoffer Evebø Sand; Benedetta Costantini; Anne Marijn Kramer; Pilar Perezabellan; Thomas Seidl; Kristin Paulsen Rye; Karen Marie Hagen; Austin Kulasekararaj; Øystein Bruserud; Ghulam J Mufti
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

9.  HMGB1 promotes myeloid-derived suppressor cells and renal cell carcinoma immune escape.

Authors:  Jinfeng Li; Jiajia Sun; Ruiming Rong; Long Li; Wenjun Shang; Dongkui Song; Guiwen Feng; Feifei Luo
Journal:  Oncotarget       Date:  2017-06-28
  9 in total
  35 in total

Review 1.  Immunotherapy and predictive immunologic profile: the tip of the iceberg.

Authors:  Tatiana Cunha Pereira; Paulo Rodrigues-Santos; Jani Sofia Almeida; Fábio Rêgo Salgueiro; Ana Raquel Monteiro; Filipa Macedo; Rita Félix Soares; Isabel Domingues; Paula Jacinto; Gabriela Sousa
Journal:  Med Oncol       Date:  2021-03-31       Impact factor: 3.064

2.  Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC.

Authors:  Julia Kargl; Xiaodong Zhu; Huajia Zhang; Grace H Y Yang; Travis J Friesen; Melissa Shipley; Dean Y Maeda; John A Zebala; Jill McKay-Fleisch; Gavin Meredith; Afshin Mashadi-Hossein; Christina Baik; Robert H Pierce; Mary W Redman; Jeffrey C Thompson; Steven M Albelda; Hamid Bolouri; A McGarry Houghton
Journal:  JCI Insight       Date:  2019-12-19

3.  Circulating myeloid-derived suppressors cells correlate with clinicopathological characteristics and outcomes undergoing neoadjuvant chemoimmunotherapy in non-small cell lung cancer.

Authors:  T Wen; C Su; X Cheng; Y Wang; T Ma; Z Bai; H Zhang; Z Liu
Journal:  Clin Transl Oncol       Date:  2022-01-06       Impact factor: 3.405

Review 4.  Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer.

Authors:  Qiaorui Tan; Sha Yin; Dongdong Zhou; Yajing Chi; Xiaochu Man; Huihui Li
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

Review 5.  Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients.

Authors:  Denisa Baci; Elona Cekani; Andrea Imperatori; Domenico Ribatti; Lorenzo Mortara
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

6.  Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer.

Authors:  Rui Li; Ramin Salehi-Rad; William Crosson; Milica Momcilovic; Raymond J Lim; Stephanie L Ong; Zi Ling Huang; Tianhao Zhang; Jensen Abascal; Camelia Dumitras; Zhe Jing; Stacy J Park; Kostyantyn Krysan; David B Shackelford; Linh M Tran; Bin Liu; Steven M Dubinett
Journal:  Cancer Res       Date:  2021-04-14       Impact factor: 12.701

Review 7.  Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.

Authors:  Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Cell Immunol       Date:  2020-12-31       Impact factor: 4.178

8.  Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.

Authors:  Yi Yan; Xinyan Wang; Chenan Liu; Junmei Jia
Journal:  BMC Pulm Med       Date:  2022-04-28       Impact factor: 3.320

Review 9.  Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer.

Authors:  Boris Duchemann; Jordi Remon; Marie Naigeon; Lydie Cassard; Jean Mehdi Jouniaux; Lisa Boselli; Jonathan Grivel; Edouard Auclin; Aude Desnoyer; Benjamin Besse; Nathalie Chaput
Journal:  Transl Lung Cancer Res       Date:  2021-06

Review 10.  Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy.

Authors:  Houhui Shi; Kai Li; Yanghong Ni; Xiao Liang; Xia Zhao
Journal:  Front Cell Dev Biol       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.